ANIX
Price
$4.10
Change
-$0.30 (-6.82%)
Updated
Oct 17 closing price
Capitalization
134.96M
81 days until earnings call
LGND
Price
$181.65
Change
+$0.88 (+0.49%)
Updated
Oct 17 closing price
Capitalization
3.54B
18 days until earnings call
Interact to see
Advertisement

ANIX vs LGND

Header iconANIX vs LGND Comparison
Open Charts ANIX vs LGNDBanner chart's image
Anixa Biosciences
Price$4.10
Change-$0.30 (-6.82%)
Volume$204.62K
Capitalization134.96M
Ligand Pharmaceuticals
Price$181.65
Change+$0.88 (+0.49%)
Volume$156.81K
Capitalization3.54B
ANIX vs LGND Comparison Chart in %
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. LGND commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a Hold and LGND is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (ANIX: $4.10 vs. LGND: $181.65)
Brand notoriety: ANIX and LGND are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 114% vs. LGND: 83%
Market capitalization -- ANIX: $134.96M vs. LGND: $3.54B
ANIX [@Biotechnology] is valued at $134.96M. LGND’s [@Biotechnology] market capitalization is $3.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileLGND’s FA Score has 1 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • LGND’s FA Score: 1 green, 4 red.
According to our system of comparison, LGND is a better buy in the long-term than ANIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 6 TA indicator(s) are bullish while LGND’s TA Score has 3 bullish TA indicator(s).

  • ANIX’s TA Score: 6 bullish, 4 bearish.
  • LGND’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANIX is a better buy in the short-term than LGND.

Price Growth

ANIX (@Biotechnology) experienced а -5.31% price change this week, while LGND (@Biotechnology) price change was +2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ANIX is expected to report earnings on Jan 07, 2026.

LGND is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGND($3.54B) has a higher market cap than ANIX($135M). ANIX YTD gains are higher at: 76.724 vs. LGND (69.529). ANIX has higher annual earnings (EBITDA): -11.95M vs. LGND (-45.94M). LGND has more cash in the bank: 255M vs. ANIX (16M). ANIX has less debt than LGND: ANIX (213K) vs LGND (5.74M). LGND has higher revenues than ANIX: LGND (188M) vs ANIX (0).
ANIXLGNDANIX / LGND
Capitalization135M3.54B4%
EBITDA-11.95M-45.94M26%
Gain YTD76.72469.529110%
P/E RatioN/A46.19-
Revenue0188M-
Total Cash16M255M6%
Total Debt213K5.74M4%
FUNDAMENTALS RATINGS
ANIX vs LGND: Fundamental Ratings
ANIX
LGND
OUTLOOK RATING
1..100
1722
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
7632
SMR RATING
1..100
9895
PRICE GROWTH RATING
1..100
3939
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIX's Valuation (65) in the Computer Peripherals industry is in the same range as LGND (81) in the Biotechnology industry. This means that ANIX’s stock grew similarly to LGND’s over the last 12 months.

LGND's Profit vs Risk Rating (32) in the Biotechnology industry is somewhat better than the same rating for ANIX (76) in the Computer Peripherals industry. This means that LGND’s stock grew somewhat faster than ANIX’s over the last 12 months.

LGND's SMR Rating (95) in the Biotechnology industry is in the same range as ANIX (98) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

LGND's Price Growth Rating (39) in the Biotechnology industry is in the same range as ANIX (39) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

LGND's P/E Growth Rating (91) in the Biotechnology industry is in the same range as ANIX (100) in the Computer Peripherals industry. This means that LGND’s stock grew similarly to ANIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIXLGND
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 9 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTOF1.400.14
+11.11%
Aptose Biosciences. Inc.
NNDNF18.58N/A
N/A
Nidec Corp.
FRZCF1.81N/A
N/A
Frasers Centrepoint Trust
NRXBF0.60-0.02
-3.74%
NUREXONE BIOLOGIC INC
OMGGF0.86-0.06
-6.45%
OMAI GOLD MINES CORP.

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with GLUE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then GLUE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-6.82%
GLUE - ANIX
36%
Loosely correlated
-2.52%
GLTO - ANIX
34%
Loosely correlated
-12.83%
LGND - ANIX
33%
Poorly correlated
+0.49%
KLTO - ANIX
31%
Poorly correlated
-2.93%
VERA - ANIX
30%
Poorly correlated
+2.36%
More

LGND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with AGIO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
+0.49%
AGIO - LGND
52%
Loosely correlated
+1.95%
AXON - LGND
49%
Loosely correlated
+2.84%
CRSP - LGND
47%
Loosely correlated
+1.05%
ACLX - LGND
46%
Loosely correlated
-2.09%
OCUL - LGND
44%
Loosely correlated
-2.95%
More